Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTOBRAIN: Cerebrovascular Reactivity to Nitrous Oxide in TRD
NCT04199143Completed
- Sponsor
- University Hospital Tours
- Start
- Feb 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of nitrous oxide in treatment-resistant depression (TRD) (2 arms), sponsored by University Hospital Tours. Primary endpoint: Brain Tissue Pulsatility at 3 months. Started Feb 2020; status: completed.
02
Drugs
nitrous oxide
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT04199143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199143.